|
1
|
Ferlay JSI, Ervik M, Dikshit R, Eser S,
Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012
v10, Cancer Incidence and Mortality Worldwide: IARC CancerBase 11
Lyon, France International Agency for Research on Cancer. 2013,
http://globocan.iarc.fr.
Accessed December 12, 2013.
|
|
2
|
He J and Chen W: Chinese cancer registry
annual report. Press Mil Med Sci Beijing. 2012:160–161. 2012.
|
|
3
|
Anvari K, Sima HR, Seilanian Toussi M,
Anvari A, Shahidsales S, Memar B, Aledavoud SA, Forghani MN,
Abdollahi A and Ghaffarzadegan K: EGFR expression in patients with
esophageal squamous cell carcinoma and its association with
pathologic response to preoperative chemora-diotherapy: A study in
Northeastern Iran. Arch Iran Med. 20:240–245. 2017.PubMed/NCBI
|
|
4
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003-2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar
|
|
5
|
Hashemian M, Poustchi H, Abnet CC,
Boffetta P, Dawsey SM, Brennan PJ, Pharoah P, Etemadi A, Kamangar
F, Sharafkhah M, et al: Dietary intake of minerals and risk of
esophageal squamous cell carcinoma: Results from the Golestan
Cohort Study. Am J Clin Nutr. 102:102–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM,
Taylor PR, Dong ZW, Mark SD and Dawsey SM: Zinc concentration in
esophageal biopsy specimens measured by X-ray fluorescence and
esophageal cancer risk. J Natl Cancer Inst. 97:301–306. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gaither LA and Eide DJ: Eukaryotic zinc
transporters and their regulation. Biometals. 14:251–270. 2001.
View Article : Google Scholar
|
|
8
|
Zou XN, Taylor PR, Mark SD, Chao A, Wang
W, Dawsey SM, Wu YP, Qiao YL and Zheng SF: Seasonal variation of
food consumption and selected nutrient intake in Linxian, a high
risk area for esophageal cancer in China. Int J Vitam Nutr Res.
72:375–382. 2002. View Article : Google Scholar
|
|
9
|
He Y, Jin J, Wang L, Hu Y, Liang D, Yang
H, Liu Y and Shan B: Evaluation of miR-21 and miR-375 as prognostic
biomarkers in oesophageal cancer in high-risk areas in China. Clin
Exp Metastasis. 34:73–84. 2017. View Article : Google Scholar :
|
|
10
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taccioli C, Wan S-G, Liu C-G, Alder H,
Volinia S, Farber JL, Croce CM and Fong LY: Zinc replenishment
reverses overex-pression of the proinflammatory mediator S100A8 and
esophageal preneoplasia in the rat. Gastroenterology. 136:953–966.
2009. View Article : Google Scholar
|
|
13
|
Taccioli, Chen H, Jiang Y, Liu XP, Huang
K, Smalley KJ, Farber JL, Croce CM and Fong LY: Dietary zinc
deficiency fuels esophageal cancer development by inducing a
distinct inflammatory signature. Oncogene. 31:4550–4558. 2012.
View Article : Google Scholar :
|
|
14
|
Jin J, Li Z, Liu J, Wu Y, Gao X and He Y:
Knockdown of zinc transporter ZIP5 (SLC39A5) expression
significantly inhibits human esophageal cancer progression. Oncol
Rep. 34:1431–1439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao S, Jiang Y, Zhao J, Li H, Yin X, Wang
Y, Xie Y, Chen X, Lu J, Dong Z, et al: Quercetin-3-methyl ether
inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K
and MAPK pathways. Mol Carcinog. 57:1540–1552. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cortés González R and Villaseñor Caloca R:
Esophageal cancer. Rev Gastroenterol Mex. 62:149–159. 1997.In
Spanish.
|
|
17
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fong LY, Taccioli C, Jing R, Smalley KJ,
Alder H, Jiang Y, Fadda P, Farber JL and Croce CM: MicroRNA
dysregulation and esophageal cancer development depend on the
extent of zinc dietary deficiency. Oncotarget. 7:10723–10738. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alder H, Taccioli C, Chen H, Jiang Y,
Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, et
al: Dysregulation of miR-31 and miR-21 induced by zinc deficiency
promotes esophageal cancer. Carcinogenesis. 33:1736–1744. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fong LY, Taccioli C, Jing R, Smalley KJ,
Alder H, Jiang Y, Fadda P, Farber JL and Croce CM: MicroRNA
dysregulation and esophageal cancer development depend on the
extent of zinc dietary deficiency. Oncotarget. 7:10723–1038. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grosser T, Yu Y and Fitzgerald GA: Emotion
recollected in tranquility: Lessons learned from the COX-2 saga.
Annu Rev Med. 61:17–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Y and Wu Z: MicroRNA-128 inhibits
proliferation and invasion of glioma cells by targeting COX-2.
Gene. 658:63–69. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao Q, Gu A, Wang Z and Xue Y:
MicroRNA-144 functions as a tumor suppressor in gastric cancer by
targeting cyclooxy-genase-2. Exp Ther Med. 15:3088–3095.
2018.PubMed/NCBI
|
|
25
|
Cornett AL and Lutz CS: Regulation of
COX-2 expression by miR-146a in lung cancer cells. RNA.
20:1419–1430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Espinosa-Parrilla Y, Muñoz X, Bonet C,
Garcia N, Venceslá A, Yiannakouris N, Naccarati A, Sieri S, Panico
S, Huerta JM, et al: Genetic association of gastric cancer with
miRNA clusters including the cancer-related genes MIR29, MIR25,
MIR93 and MIR106: Results from the EPIC-EURGAST study. Int J
Cancer. 135:2065–2076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu WW, Jiang H, Zhang CT and Peng Y: The
SNAIL/miR-128 axis regulated growth, invasion, metastasis, and
epithelial-to-mesen-chymal transition of gastric cancer.
Oncotarget. 8:39280–39295. 2017.PubMed/NCBI
|
|
28
|
Takahashi Y, Iwaya T, Sawada G, Kurashige
J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, et al:
Up-regulation of NEK2 by microRNA-128 methylation is associated
with poor prognosis in colorectal cancer. Ann Surg Oncol.
21:205–212. 2014. View Article : Google Scholar
|
|
29
|
Feng Z, Xia Y, Gao T, Xu F 1, Lei Q 1,
Peng C 2, Yang Y 3, Xue Q 1, Hu X 1, Wang Q, et al: The
antipsychotic agent trifluoperazine hydrochloride suppresses
triple-negative breast cancer tumor growth and brain metastasis by
inducing G0/G1 arrest and apoptosis. Cell Death Dis. 9:10062018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia
HH, He H, Feng HC, Wang LD, Gu Q, Lam SK, et al: Early upregulation
of cyclooxygenase-2 in human papillomavirus type 16 and
telom-erase-induced immortalization of human esophageal epithelial
cells. J Gastroenterol Hepatol. 23:1613–1620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu B, Wen JK, Li BH, Fang XM, Wang JJ,
Zhang YP, Shi CJ, Zhang DQ and Han M: Celecoxib and
acetylbritannilactone interact synergistically to suppress breast
cancer cell growth via COX-2-dependent and -independent mechanisms.
Cell Death Dis. 28:e1852011. View Article : Google Scholar
|
|
32
|
Yoshida A, Fujiwara T, Uotani K, Morita T,
Kiyono M, Yokoo S, Hasei J, Nakata E, Kunisada T and Ozaki T:
Clinical and functional significance of intracellular and
extracellular microRNA-25-3p in osteosarcoma. Acta Med Okayama.
72:165–174. 2018.PubMed/NCBI
|
|
33
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Komatsu S, Ichikawa D, Kawaguchi T,
Miyamae M, Okajima W, Ohashi T, Imamura T, Kiuchi J, Konishi H,
Shiozaki A, et al: Circulating miR-21 as an independent predictive
biomarker for chemoresistance in esophageal squamous cell
carcinoma. Am J Cancer Res. 6:1511–1523. 2016.PubMed/NCBI
|
